Perceptive Advisors LLC sold $2.7M of ACRV
owner at Acrivon Therapeutics, Inc.. 1,519,952 shares at an average of $1.81, traded Apr 25, 2025, filed Apr 29, 2025.
Score components
- +12Role10% owner
- +25Trade size$2.7M at market
- +10Share of holdings soldSold 28% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-25-008214, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | SOpen-market sale Common Stockindirect: See Footnote | -1,054,669 | $1.95 | $2.1M | 4,306,189 | Apr 29, 2025 |
| Apr 28, 2025 | SOpen-market sale Common Stockindirect: See Footnote | -215,283 | $1.56 | $336k | 4,090,906 | Apr 29, 2025 |
| Apr 29, 2025 | SOpen-market sale Common Stockindirect: See Footnote | -250,000 | $1.41 | $353k | 3,840,906 | Apr 29, 2025 |
Related signals
Other insiders at Acrivon Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | ACRVsell Acrivon Therapeutics, Inc. | Mary Miller Chief Legal Officer | $585 294 shares | -0% | |
| 42Moderate | ACRVsell Acrivon Therapeutics, Inc. | Perceptive Advisors LLC owner | $1.0M 736,767 shares | -19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.